CRVS

Corvus Pharmaceuticals Stock Analysis

AI Rating

Low
  • Quality1/10
  • Growth↓ 0/10
  • Value↑ 6/10
Corvus Pharmaceuticals sales and earnings growth
CRVS Growth
Low
  • Revenue Y/Y↓ 0.00%
  • EPS Y/Y↑ 16.13%
  • FCF Y/Y↓ -23.02%
Corvus Pharmaceuticals gross and profit margin trends
CRVS Profitability
Low
  • Gross margin ↓ 0.00%
  • EPS margin↓ 0.00%
  • ROIC 5Y↓ -103.36%
Corvus Pharmaceuticals net debt vs free cash flow
CRVS Risk
Great
  • Debt / Equity↓ 0.0
  • Debt / FCF↓ 0.0
  • Interest coverage↓ NA

Corvus Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Great risk rating.

↗ More Biotechnology stocks